Lauder CEO Addresses Disbanded Puig Deal
By Maksym Misichenko · Yahoo Finance ·
By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
Estée Lauder's walk from Puig reflects disciplined capital allocation, but the company faces significant challenges in fragrance penetration and execution of its Profit Recovery and Growth Plan (PRGP).
Risk: Failure to execute the PRGP and achieve margin expansion, particularly in the face of a persistent slowdown in China.
Opportunity: Potential margin gains from the PRGP funding M&A or organic growth initiatives, if China demand normalizes.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
PARIS — The “elephant in the room” was quickly addressed during the Estée Lauder Cos.’ panel at the Deutsche Bank Global Consumer Conference, held in Paris Tuesday morning.
“A year ago, when we were on this stage, we spoke a bit about portfolio optimization,” said Stephen Powers, managing director, head of U.S. consumer packaged goods research at Deutsche Bank AG, addressing Stéphane de La Faverie, president and chief executive officer of the Estée Lauder Cos. “And in that context, the conversation was mostly about organic optimization over time. Just to address probably the elephant in the room: You’ve obviously since that time looked at a very large acquisition of a portfolio of brands, and you’ve continued to be active in minority and majority investments in other assets, as well as hiring advisers to overall do a portfolio review.”
The large deal referred to was a possible merger with Puig, before talks officially ended on May 21.
“As we reset and think about the business and your strategy from here, how do we think about the role of M&A going forward?” Powers asked. “Do you have the right portfolio of brands to achieve what your aspirations are, or do you need something more transformational from an M&A perspective to achieve the value creation targets that you set?”
De La Faverie said Beauty Reimagined, Lauder’s five-part strategic plan, is about the rebalancing of company growth from a geographic, category and channel standpoint.
“It is true when you look at the portfolio of the Estée Lauder Companies in prestige beauty, we are the leader in skin care around the world, with a very strong position in Asia-Pacific and many other markets around the world,” he said. “We are the leader in makeup, especially with brands like MAC.”
But fragrance is the smallest product category for the group among the largest categories.
“We are extremely proud of the portfolio of luxury brands — artisanal niche — however people are calling them that we have, from Le Labo to Tom Ford, Jo Malone, Kilian and so on and so forth,” de La Faverie said. “But it is true that when you go from east to west, the more west you go, the higher the penetration of prestige fragrances is, especially in Europe and in Latin America.”
In Europe, roughly 40 percent to 50 percent of the business is generated from prestige fragrances, while in Latin America that can be upward of 50 percent or 60 percent.
“We have less of a presence on this,” de La Faverie said. “So when — if — an opportunity one day comes, we can look at it. But I want to be very clear: It has to be accretive from a growth standpoint. It has to be accretive from a profitability standpoint over time. It has to create shareholder values. And if we cannot reach the growth and the profitability at the right price point, then that is not an option. This is why this deal didn’t go through, because it was not at the right price.”
He said as the president and CEO of the Estée Lauder Cos., he would never do anything that does not make sense financially for the company or its shareholders.
“Strategically it may make sense because the complementarity of the portfolio [is] very interesting, but it has to make sense financially,” de La Faverie said, adding that Lauder will continue to look at opportunities, even though M&A not at the heart of Beauty Reimagined.
“One of the things that people have questioned is: ‘Is it the right time?’” de La Faverie said, of major deal-making. He explained that as part of the company’s Profit Recovery and Growth Plan, or PRGP, Lauder is in the midst of a major transformation from an operational, cultural and leadership standpoint.
“This transformation in 29 days is over in terms of approval of the PRGPs,” de La Faverie said, adding the transformation’s execution will largely be complete by the end of the current calendar year. “Which allows us to [make a] more transformational deal if we decide to in the future. But, again, it has to be at the right price, and it has to make sense within the existing portfolio of the Estée Lauder Companies.”
In answer to the question about whether Lauder has the right portfolio of brands to compete in today’s prestige beauty market, de La Faverie said: “The answer is absolutely ‘yes.’
“We have a fantastic portfolio of brands,” he said. “We have many markets around the world where we’re getting market share — China, even in the U.S. — we are on the right trajectory in the emerging markets online around the world.”
The executive explained Lauder divides its brand portfolio into three groups: large brands that are a billion dollars or close to that and more; brands between $500 million and $1 billion in net sales, and the smaller brands.
“Our large and midsized brands are very, very good,” de La Faverie said. “And we have some really up-and-coming smaller brands that are growing fast. Think about a brand like Kilian, that now is the fastest-growing brand in the company. We have Le Labo as a midsized brand that is the second fastest-growing brand in the company.”
The Ordinary is performing extremely well, too, while La Mer, among Lauder’s largest brands, is gaining share in practically every market globally.
“I am very proud of the portfolio of brands,” de La Faverie said, adding that last year while on the Deutsche Bank stage, there were questions surrounding whether Lauder’s brands were impaired after three years of company deleverage. That compares to today, when the group is registering market share growth.
“It is the proof that our portfolio of brands is very strong. But I’ve also been very public that we will be part of the M&A discussion,” de La Faverie said. “We’ve always been part of the M&A conversation.”
Of the company’s 25-plus brands, just four were created by the group, he reminded.
“Sometimes, we have to revisit the portfolio, and we are looking at it,” de La Faverie continued, reiterating Lauder has hired advisers to review some of the brands. “Sometimes brands don’t fit anymore the consumer needs.”
Four leading AI models discuss this article
"Lauder's ongoing portfolio optimization and M&A optionality create upside through selective bolt-ons and efficiency gains, not a transformational deal."
Headline focus on Puig misses the real signal: Lauder is baking optionality into Beauty Reimagined. The insistence that any future M&A must be accretive and at the right price doesn't rule out smaller, highly strategic bolt-ons, especially in fast-growing niches (Le Labo, Kilian) or in Asia/Latin America where Prestige share growth remains resilient. The portfolio review and adviser involvement imply pruning capital that may free cash flow for buybacks or smaller deals that can lift growth without blowing up leverage. Yet execution risk remains high: market demand, China slowdown, and PRGP timing could underperform, and the market may punish if no near-term accretive deal materializes.
Puig’s collapse shows the M&A bar is very high; in a slowing macro, big deals are unlikely and relying on bolt-ons may prove insufficient to drive upside if luxury demand softens or pricing power wanes.
"Estée Lauder’s focus on internal restructuring and portfolio pruning masks a lack of clear strategic direction to address their structural under-exposure to the high-growth prestige fragrance category."
Estée Lauder (EL) management is attempting to frame the collapsed Puig deal as a disciplined 'price-sensitive' decision, but the underlying narrative suggests a company in defensive mode. By emphasizing the Profit Recovery and Growth Plan (PRGP) and portfolio reviews, they are signaling that the house is not yet in order. While they correctly identify fragrance as a growth lever—especially in Western markets—the reliance on 'organic' growth in a volatile Chinese market remains a significant headwind. Management’s assertion that they have the 'right' portfolio is contradicted by the fact that they are actively hiring advisers to prune underperforming assets. Until we see tangible margin expansion from the PRGP, this looks like a turnaround story lacking a catalyst.
If the PRGP successfully rights the cost structure by year-end, EL’s high-margin prestige portfolio could see significant EPS leverage, making the current valuation an attractive entry point before the next cycle of M&A begins.
"Lauder's fragrance underweight in high-penetration Western markets is a structural competitive disadvantage that M&A discipline alone cannot solve without a transformational deal—which the Puig collapse signals may not materialize."
De La Faverie's messaging is disciplined damage control masking a strategic retreat. Lauder walked from Puig because valuations didn't work—a rational call—but the real tell is fragrance exposure. Lauder admits it's underweight in Europe (40-50% prestige fragrance penetration) and Latin America (50-60%), categories where competitors like Hermès and LVMH dominate. The 'right price' language is cover for: Puig wanted too much, and Lauder lacks organic fragrance scale to compete. Beauty Reimagined is operational triage, not growth. Market share gains in China and The Ordinary don't offset fragrance gap in high-margin Western markets.
Lauder's disciplined capital allocation and refusal to overpay may be exactly what shareholders need after years of deleveraging; if PRGP execution delivers margin recovery by year-end, the company could be a takeout target itself at a lower multiple, making today's 'no' strategically sound.
"Lauder’s post-Puig stance signals capital discipline but leaves the fragrance exposure gap unaddressed by M&A for the foreseeable future."
Estée Lauder’s CEO framed the Puig talks collapse as disciplined capital allocation rather than portfolio weakness, stressing that any future deal must be accretive on both growth and margins while the PRGP transformation wraps by year-end. The commentary highlights share gains in China and the U.S. plus fast-growing niche fragrance brands like Kilian, yet concedes prestige fragrance remains structurally underweight in Europe and Latin America. With M&A explicitly not central to Beauty Reimagined, investors get clarity on near-term priorities but little visibility on how organic initiatives alone close the category gap. Execution risk on the 29-day PRGP approval-to-delivery timeline is the unaddressed variable.
The CEO’s insistence that the portfolio is already sufficient could mask competitive erosion if prestige fragrance demand continues shifting toward European and Latin American markets where Lauder’s presence is lightest and rival scale matters more than niche artisanal positioning.
"Puig's collapse may reflect pricing dynamics rather than structural fragrance limitations, and if PRGP margin expansion materializes via Kilian/Le Labo in Asia, Lauder could still unlock value even without Europe uplift."
Claude overemphasizes the Europe/Latin America fragrance gap as a structural flaw. But the Puig episode isn't proof Lauder can't scale fragrance; it could reflect a price-sensitivity buyer plus a repositioning window. The real risk is PRGP execution timing and whether Kilian/Le Labo can scale profitably in Asia, not just share gains in China. If PRGP delivers 100-150bp margin lift by year-end, Lauder could still unlock value even without Europe uplift.
"The PRGP is a liquidity-constrained pivot that ignores the reality that Lauder lacks both the capital for M&A and the organic growth to offset China's structural decline."
Claude and ChatGPT are missing the liquidity trap: Lauder’s balance sheet is constrained by the PRGP’s cash burn, limiting their ability to pivot if organic growth stalls. Relying on 150bp of margin expansion is a pipe dream if the China slowdown persists; that market is where they need operating leverage, not just cost-cutting. If the PRGP fails to hit, they aren't just 'underweight' in fragrance—they are structurally impaired, with no M&A dry powder to compensate.
"PRGP liquidity risk is overstated; China demand normalization is the real gate for any upside thesis."
Gemini's liquidity trap argument is real, but it conflates two separate risks. PRGP cash burn is temporary and front-loaded; the structural constraint is China exposure, not working capital. If China demand normalizes, margin expansion funds M&A optionality. The actual trap: if China *doesn't* normalize, 150bp margin gains evaporate regardless of PRGP execution. That's the unspoken base case nobody's pricing.
"Niche fragrance brands cannot close Lauder's Europe/LatAm gap without scale even if China recovers."
Claude separates PRGP cash burn from China exposure but misses how this compounds the fragrance gap. Even if China normalizes, Lauder's niche plays like Kilian lack distribution scale to lift Europe and Latin America penetration from 40-50% levels where LVMH and Hermès already dominate. PRGP margin gains then fund neither M&A nor organic catch-up, exposing share erosion as the binding constraint rather than timing alone.
Estée Lauder's walk from Puig reflects disciplined capital allocation, but the company faces significant challenges in fragrance penetration and execution of its Profit Recovery and Growth Plan (PRGP).
Potential margin gains from the PRGP funding M&A or organic growth initiatives, if China demand normalizes.
Failure to execute the PRGP and achieve margin expansion, particularly in the face of a persistent slowdown in China.